BioForce Nanosciences Holdings, Inc.
BFNH · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $67 | $472 | $486 | $502 |
| SG&A Expenses | $67 | $472 | $486 | $502 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $423 | $0 | $0 | $0 |
| Operating Expenses | $490 | $472 | $486 | $502 |
| Operating Income | -$490 | -$472 | -$486 | -$502 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | -$490 | -$472 | -$486 | -$502 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$490 | -$472 | -$486 | -$502 |
| % Margin | – | – | – | – |
| EPS | -0.017 | -0.016 | -0.017 | -0.017 |
| % Growth | -4.3% | 3% | 2.9% | – |
| EPS Diluted | -0.017 | -0.016 | -0.017 | -0.017 |
| Weighted Avg Shares Out | 29,272 | 29,272 | 29,272 | 29,272 |
| Weighted Avg Shares Out Dil | 29,272 | 29,272 | 29,272 | 29,272 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $472 | $0 | $0 |
| EBITDA | -$490 | $0 | -$486 | -$502 |
| % Margin | – | – | – | – |